Methods and compositions for inducing an immune response to egfrviii
AssigneesAduro Biotech, Inc., Providence Health & Services - Oregon d/b/a Providence Portland Medical Center
InventorsPeter M. Lauer, Keith Bahjat
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of inducing a T-cell response against a EGFRvIII in a subject. These method comprise administering to a subject a composition which expresses at least one immunogenic polypeptide, the amino acid sequence of which comprise a plurality of EGFRvIII polypeptide sequences, the sequence of which each comprise EEKKGNYV (SEQ ID NO: 3), and/or administering the polypeptide itself.
Claims28
A method of expressing an EGFRvIII polypeptide in a subject, said method comprising:
- recombinantly expressing at least one polypeptide, the amino acid sequence of which comprise a plurality of EGFRvIII polypeptide sequences, the sequence of which each comprise EEKKGNYV (SEQ ID NO:
- 3), in said subject.
An isolated nucleic acid molecule encoding at least one immunogenic polypeptide, the amino acid sequence of which comprise a plurality of EGFRvIII polypeptide sequences, the sequence of which each comprise EEKKGNYV (SEQ ID NO:
- 3).
Dependencies are inferred from the claim text.